[Respiratory syncitial virus in immunocompromised patients in a pediatric hospital: 5 years experience].
作者信息
Domínguez-Pinilla N, Belda Hofheinz S, Vivanco Martinez J L, Baro-Fernández M, Ruiz-Contreras J, González-Granado L I
机构信息
Unidad de Hemato-Oncología Pediátrica, Hospital 12 de Octubre, Madrid, España.
Unidad de Cuidados Intensivos Pediátricos, Hospital 12 de Octubre, Madrid, España.
出版信息
An Pediatr (Barc). 2015 Jan;82(1):35-40. doi: 10.1016/j.anpedi.2014.04.016. Epub 2014 Jun 2.
INTRODUCTION
Respiratory syncytial virus (RSV) infection is associated with an increase in morbidity and mortality in immunocompromised hosts.
METHODS
A description is presented of all cases of RSV infection in immunocompromised pediatric patients in Hematology and Oncology and Immunodeficiency Units between 2008 and 2012.
RESULTS
Nineteen patients were diagnosed with RSV infection. Nine patients required in-patient care and 2 required Pediatric Intensive Care Unit. Five patients were treated with specific therapy (ribavirin ± palivizumab). No deaths occurred in the study period.
CONCLUSION
RSV infection may be severe in immunocompromised pediatric patients.
Zotero 插件